Understanding the “Burden of Worry”: New insights from PROgress Tracker Breast Cancer Registry When someone finishes active breast cancer treatment, it’s often seen as the end of the medical journey. But for
What Happens After the “All Clear”? Breast Cancer Canada Calls for Urgent Action to Support Canadian Breast Cancer Survivors As more younger Canadians are being diagnosed with breast cancer and
Beyond the Treatment Calendar: Reflecting on Breast Cancer The American Society of Clinical Oncology (ASCO) Annual Meeting is famously known as the place where ground-breaking clinical trials make their global
mBC Treatment Discussions at ASCO 2026 One of the most discussed themes at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was how treatment decisions are evolving for
One of the most discussed themes at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was the continued shift toward personalized treatment for early breast cancer. Researchers presented
Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget Recommendation 1: That the Government of Canada, through the Public Health Agency of Canada, formally recognize and
For the first time in Canada, the country’s leading breast cancer experts have come together to establish national standards for breast cancer. This suite of publications released in Current Oncology
Dr. Mita Manna, Medical Oncologist at the Saskatoon Cancer Centre and associate professor at the University of Saskatchewan, recently delivered an inspiring talk on the future of breast cancer care
Breast Cancer Canada is pleased to announce the awarding of eight new scholarships and fellowships at the Breast Cancer Canada Translational Research Unit (BCC-TRU) at London Health Sciences. These awards
Breast Cancer Canada warmly invites you to Canadian Night at ASCO 2026, a special evening to connect with Canadian researchers, patient advocates, and healthcare leaders while celebrating progress in breast
Quick Links
Sign Up, Know More.
